Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    David Schairer

    TitleResident Physician
    SchoolUniversity of California, San Diego
    DepartmentDermatology
    Address9500 Gilman Drive #0975
    CA La Jolla 92093
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Iammatteo M, Akenroye A, Jariwala S, Lee B, Schairer D, Rosenstreich D. Severe contact dermatitis due to ethylenediamine dihydrochloride in nystatin cream. J Allergy Clin Immunol Pract. 2017 Sep - Oct; 5(5):1448-1450. PMID: 28396110.
        View in: PubMed
      2. Doerner JL, Wen J, Xia Y, Paz KB, Schairer D, Wu L, Chalmers SA, Izmirly P, Michaelson JS, Burkly LC, Friedman AJ, Putterman C. TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus. J Invest Dermatol. 2015 Aug; 135(8):1986-1995. PMID: 25826425; PMCID: PMC4504782.
      3. Charafeddine RA, Makdisi J, Schairer D, O'Rourke BP, Diaz-Valencia JD, Chouake J, Kutner A, Krausz A, Adler B, Nacharaju P, Liang H, Mukherjee S, Friedman JM, Friedman A, Nosanchuk JD, Sharp DJ. Fidgetin-Like 2: A Microtubule-Based Regulator of Wound Healing. J Invest Dermatol. 2015 Sep; 135(9):2309-2318. PMID: 25756798; PMCID: PMC4537388.
      4. Schairer D, Chouake JS, Kutner AJ, Makdisi J, Nosanchuk JD, Friedman AJ. Evaluation of the antibiotic properties of glutathione. J Drugs Dermatol. 2013 Nov; 12(11):1272-7. PMID: 24196336.
        View in: PubMed
      5. Schairer LC, Foley FW, Zemon V, Tyry T, Campagnolo D, Marrie RA, Gromisch ES, Schairer D. The impact of sexual dysfunction on health-related quality of life in people with multiple sclerosis. Mult Scler. 2014 Apr; 20(5):610-6. PMID: 23999609.
        View in: PubMed
      6. Sanchez DA, Schairer D, Tuckman-Vernon C, Chouake J, Kutner A, Makdisi J, Friedman JM, Nosanchuk JD, Friedman AJ. Amphotericin B releasing nanoparticle topical treatment of Candida spp. in the setting of a burn wound. Nanomedicine. 2014 Jan; 10(1):269-77. PMID: 23770066.
        View in: PubMed
      7. Pompei DT, Rezzadeh KS, Viola KV, Lee DH, Schairer D, Chismar LA, Cohen SR. Cantharidin therapy: practice patterns and attitudes of health care providers. J Am Acad Dermatol. 2013 Jun; 68(6):1045-6. PMID: 23680201.
        View in: PubMed
      8. Chouake J, Schairer D, Kutner A, Sanchez DA, Makdisi J, Blecher-Paz K, Nacharaju P, Tuckman-Vernon C, Gialanella P, Friedman JM, Nosanchuk JD, Friedman AJ. Nitrosoglutathione generating nitric oxide nanoparticles as an improved strategy for combating Pseudomonas aeruginosa-infected wounds. J Drugs Dermatol. 2012 Dec; 11(12):1471-7. PMID: 23377518.
        View in: PubMed
      9. Friedman AJ, Phan J, Schairer D, Champer J, Qin M, Pirouz A, Blecher-Paz K, Oren A, Liu PT, Modlin RL, Kim J. Antimicrobial and anti-inflammatory activity of chitosan-alginate nanoparticles: a targeted therapy for cutaneous pathogens. J Invest Dermatol. 2013 May; 133(5):1231-9. PMID: 23190896; PMCID: PMC3631294.
      10. Schairer D, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012 May 01; 3(3):271-9. PMID: 22546899; PMCID: PMC3442839.
      11. Schairer D, Schairer L, Friedman A. Psychology and psychiatry in the dermatologist's office: an approach to delusions of parasitosis. J Drugs Dermatol. 2012 Apr; 11(4):543-5. PMID: 22453598.
        View in: PubMed
      12. Blecher K, Martinez LR, Tuckman-Vernon C, Nacharaju P, Schairer D, Chouake J, Friedman JM, Alfieri A, Guha C, Nosanchuk JD, Friedman AJ. Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice. Nanomedicine. 2012 Nov; 8(8):1364-71. PMID: 22406184.
        View in: PubMed
      13. Schairer D, Martinez LR, Blecher K, Chouake J, Nacharaju P, Gialanella P, Friedman JM, Nosanchuk JD, Friedman A. Nitric oxide nanoparticles: pre-clinical utility as a therapeutic for intramuscular abscesses. Virulence. 2012 Jan-Feb; 3(1):62-7. PMID: 22286699; PMCID: PMC3337151.
      14. Schairer D, Friedman A. Manifestations and treatment of cutaneous lupus erythematosus (Part II of II). J Drugs Dermatol. 2011 Dec; 10(12):1474-6. PMID: 22134575.
        View in: PubMed
      15. Schairer D, Levis WR. Letter to the editor--atrial fibrillation: an inflammatory and autoimmune disorder. Heart Rhythm. 2012 Feb; 9(2):e2; author reply e2-3. PMID: 22100332.
        View in: PubMed
      16. Schairer D, Friedman A. Manifestations and treatment of cutaneous lupus erythematosus (part I of II). J Drugs Dermatol. 2011 Oct; 10(10):1212-4. PMID: 21968677.
        View in: PubMed
      17. Friedman AJ, Blecher K, Schairer D, Tuckman-Vernon C, Nacharaju P, Sanchez D, Gialanella P, Martinez LR, Friedman JM, Nosanchuk JD. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione. Nitric Oxide. 2011 Nov 30; 25(4):381-6. PMID: 21946032.
        View in: PubMed